Log In
Print
BCIQ
Print
Print this Print this
 

EDP-239

  Manage Alerts
Collapse Summary General Information
Company Enanta Pharmaceuticals Inc.
DescriptionNon-structural protein 5A (NS5A) inhibitor
Molecular Target HCV NS5A protein
Mechanism of ActionHCV non-structural protein 5A inhibitor
Latest Stage of DevelopmentPhase I
IndicationHepatitis C virus (HCV)
Partner

Novartis AG
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today